This title has ceased (2017)
Aims & Scope: Endocrine Disruptors is a unique focus peer-reviewed journal with a broad international audience. It will publish high-quality research addressing all aspects of how endocrine-active contaminants dupe the hormonal signaling system into inappropriate communication, and how we can intervene. The goal of our journal is to present top-notch and thought-provoking papers that will provide a better understanding of how these compounds operate. Such understanding will lead to solutions that address the hazards that endocrine disruptors pose to humans, wildlife, and the environment
Endocrine Disruptors publishes articles of different formats including: Original Research Papers, Brief Reports, Reviews & Mini-Reviews, Meeting Reports and Commentary. The latter three categories will generally be invited, and will cover current topics and recent advances in the field. We will also publish special issues devoted to particular areas of endocrine disruption.
Endocrine Disruptors will cover the following topics. Suggestions for additional specialized topics are welcome:
- Signaling mechanisms - endocrine disruption by chemicals that mimic/antagonize all classes of hormones: reproductive and metabolic hormones, morphogens, detoxification systems, vitamins, and orphans--via all hormone binding proteins and metabolic pathways.
- Endocrine disruption-based disease - e.g. reproductive, developmental, immunologic, metabolic, behavioral, oncologic-including both preclinical and epidemiologic studies.
- High throughput, structure-based, and modeling methodologies - in silico compound docking, medium→high throughput screening methods, structure-activity studies, and database approaches. The study of mixtures, low-doses, non-monotonic dose behavior, and their environmental relevancy.
- Experimental models - the suitability of cell and animal models for assessing endocrine disruptor activities.
- Perinatal origins of adult disease - the fetal, postnatal and multigenerational basis of adult disease, and emerging examples of epigenetic control and endocrine disruptor-mediated imprinting of changes in gene expression.
- Natural endocrine disruptors - e.g. phyto-hormones, phyco-hormones- and their disease, drug interaction, or therapeutic targets.
- Cross-training for chemists and biologists- facilitating the interface of green chemistry design/remediation with endocrinology, aimed at eliminating future endocrine-disrupting chemicals from consumer products.
- Public policy - the crafting of public policy to prevent and remediate endocrine disruption.
- Education and Outreach - community outreach, public education, translation to stake-holders, and web sites devoted to exposing or solving the endocrine disruption problem.
Submission is online at
http://endodis.msubmit.net/cgi-bin/main.plex. All submitted manuscripts are subject to initial appraisal by the Editor-in-Chief, in consultation with the Associate Editors, and, if found suitable for further consideration, to peer review by independent, anonymous expert referees. The editorial board will consider manuscripts and accompanying reviewer reports from established journals in the field for fast tracked decisions. If there are any questions, please contact the Editor-in-Chief.
Taylor & Francis Open Access License Agreement Endocrine Disruptors is an Open Access journal, all accepted manuscripts will be freely available online immediately upon publication. All authors must sign one of the Open Access License Agreements.
| Open Access License | Type of Paper | Fee |
| CC-BY-NC license | Report Short Report Commentary & Other | $1050 $785 $525 |
| CC-BY license | Report Short Report Commentary & Other | $2100 $1575 $1050 |
Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})